Newsletter | August 25, 2020

08.25.20 -- Discovery Promising For Millions At Risk From Antibiotic Resistance

Industry Insights
Avoid The Fallout From Incompatibility Between Your API And Its Formulation

It is critical the experts creating a drug product’s formulation are aware of any reactions that can occur between an API and a tablet’s excipients.

In Vitro Test Methodologies To Characterize Bioavailability Enhancing Formulations

Some of the most important technologies available to formulators are those that enhance bioavailability, given the large percentage of low-solubility compounds in today’s pharmaceutical pipelines. Formulators have many choices in their toolkit when it comes to bioavailability enhancement, so the tough call becomes which one to use for a given compound. Lonza has developed a full complement of tools that accurately predict the performance of bioavailability-enhanced formulations.

Choosing The Best Sterile Dosage Form For Your Phase 1 Needs

When developing a parenteral product, pharmaceutical scientists are faced with a variety of choices — choices that can be conflicting or present differing advantages.

Protein Analysis With Size Exclusion Chromatography (SEC)

This white paper presents fundamentals about analytical SEC and describes how our new-generation agarose-based SEC columns are used in analysis of biomolecules.

Why Are Lipid Formulations Commonly Used To Enhance Bioavailability?

A discussion on potential mechanisms of increased absorption with lipid formulations, screening tools used during the development of these formulations, scale up, and industrialization considerations. 

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.